Goldman Sachs’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Buy |
|
|||||
|
2025
Q1 | $2.19M | Sell |
|
|||||
|
2024
Q4 | $5.78M | Sell |
|
|||||
|
2024
Q3 | $6.54M | Sell |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | $5.93M | Buy |
|
|||||
|
2023
Q4 | $2.56M | Buy |
|
|||||
|
2023
Q3 | $740K | Buy |
|
|||||
|
2023
Q2 | $138K | Sell |
|
|||||
|
2023
Q1 | $796K | Buy |
|
|||||
|
2022
Q4 | $151K | Sell |
|
|||||
|
2022
Q3 | $199K | Buy |
|
|||||
|
2022
Q2 | $124K | Buy |
|
|||||
|
2022
Q1 | $152K | Buy |
|
|||||
|
2021
Q4 | $177K | Buy |
|